皮下注射针市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00007734
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 212
Buy Now

市场洞察

2021 年全球皮下注射针头市场规模为 351,953 万美元,预计到 2028 年将达到 552928 万美元,2021 年复合年增长率为 6.7% ;2028。

慢性病患病率的不断上升和疫苗需求的激增是促进市场增长的潜在参数,而替代品的可用性则阻碍了全球皮下注射针头市场的扩张。

患病率高血源性疾病的发生、政府积极参与实施严格的法规、对注射药物和疫苗的需求不断增加以及新兴经济体尚未开发的潜力是推动安全针头市场增长的主要因素。主要市场参与者一直专注于产品推出和扩张等有机战略,同时也参与合作和伙伴关系等无机发展,以增强其区域主导地位。有机发展占战略增长的 60%,无机活动占整个组织发展的 40%。

从地区来看,北美占据了全球皮下注射针头市场的主要份额,并且很可能会继续增长。在整个预测期内保持其主导地位。亚太地区在预测期内的复合年增长率可能最高。

COVID-19 影响

大流行期间对针头和注射器的巨大需求激增,导致全球皮下注射剂的增长针头市场

全球 COVID-19 大流行导致入院人数增加,随后的检查和药物治疗刺激了市场增长。 COVID-19 疫苗接种的增加导致对针头和注射器的巨大需求。疫苗运动强调了针头的实用性。主要市场参与者利用这个机会来满足对一次性针头前所未有的需求。大流行需要快速开发疫苗来遏制这种疾病。批准用于预防 COVID-19 的疫苗是使用皮下注射针进行肌肉注射和皮下注射。多家制造商保持了强大的供应链,以满足大流行期间持续接种疫苗的要求。

2021年1月,BD公司向美国各医院分发了8亿支注射器和针头,因为该公司与冠状病毒密切合作美国卫生与公共服务部特别工作组。由于意大利、德国、法国、西班牙和英国报告的新冠病例数量最多,欧洲的皮下注射针头市场出现了大幅增长。 2020年7月,BD从英国政府收到了6500万支针头和注射器的巨额订单,以支持该国的疫苗接种工作。在亚太地区,疫情对全球皮下注射针头市场造成了适度打击。该地区的低收入国家面临医疗基础设施短缺和供应链中断的问题。然而,市场参与者热衷于医疗发展,看到了对皮下注射针头的需求。三泽医疗工业开发出“低死腔针”可以减少注射器中残留的药液量。

未来趋势

皮下注射针设计的技术进步

制药行业已经见证了大量先进的干预措施来治疗多种慢性疾病。人们越来越需要能够让患者或非临床医生安全注射药物的设备。无针喷射注射器是替代方案之一,但它相对昂贵且不太适合广泛推广。因此,整合先进技术使皮下注射针更符合人体工程学变得至关重要。 2020 年 8 月,麻省理工学院的科学家开发了一种皮下注射针原型,其注射器包含两个装有粘性药物和生物相容性润滑液的针筒。多家制造商正在研究精密设计的针头和防针刺技术,以在具有挑战性的应用中表现出色。大多数公司都提供安全的设计和较少痛苦的注射,以确保治疗成功。皮下注射针头正在接受受控制造和严格检查,以确保质量。

驱动因素

慢性病患病率增加

糖尿病、心血管疾病、自身免疫性疾病等慢性病,各种类型的癌症是导致死亡和残疾的主要原因。根据美国疾病控制与预防中心 (CDC) 的数据,2019 年,美国每 10 个人中就有大约 6 人患有至少一种慢性疾病。心血管疾病在全球范围内造成很高的死亡率,估计每年有 1,790 万例死亡病例年。糖尿病是另一种危及生命的慢性疾病,无法进行功能性治愈。外源性胰岛素通常通过皮下途径给予糖尿病患者。皮下注射针用于胰岛素输送的广泛接受,使得自我管理和准确剂量成为可能,推动了皮下注射针市场的发展。此外,大多数生物治疗药物都是使用皮下针注射进行注射,因为它们可以提供低成本、快速和直接的分子递送。

疫苗需求激增

根据世界卫生组织的数据,大约全球 90% 的注射用于治疗。免疫注射占5%左右。对疫苗的需求不断增长已成为全球皮下注射针头市场增长的关键因素。此外,全民免疫计划(UIP)提供的可预防疾病免疫覆盖率的提高正在推动市场增长。联合国儿童基金会的共同努力使疫苗变得更安全、更容易获得。除此之外,COVID-19 疫苗的推出凸显了针头、注射器和其他免疫工具的关键作用。 2020 年 7 月,作为“曲速疫苗行动”计划的一部分,史密斯医疗公司与美国政府合作,获得了 2000 万美元的投资,用于增加注射器和针头的产量。

限制

< h3>替代方案的可用性

 针头注射的缺点是众所周知的。大量人口群体都记录了对自我注射的心理抵制或针头恐惧症。在糖尿病管理方面,可穿戴式注射器、笔式注射器和无针注射器等自我注射系统为患者提供了无与伦比的治疗控制权,从而限制了皮下注射针头市场的增长。微针的使用因其微创、减轻疼痛和抗感染而受到关注,最终抑制了相关市场的增长。此外,皮下注射针市场还面临着无针注射器带来的激烈竞争,这些注射器技术先进,可管理高粘度的药品。这些对皮下注射针头的使用构成挑战的替代品可能会阻碍市场增长。

战略见解

市场细分

按类型

< h3>相对于传统注射器的临床优势刺激了细分市场的增长

全球皮下注射针头市场按类型分为安全针头和非安全针头。前者在 2021 年占据最大的市场份额,预计在预测期内将以最高复合年增长率飙升。安全注射器具有内置安全机制,可降低针刺伤害的风险。一些国家已出台法规来确保使用安全注射器并防止重复使用针头。与传统注射器相比,这有助于加快安全注射器的使用。提供安全针头的主要参与者包括 BD 和 Cardinal Health。 BD 生产主动和被动针头安全系统,Cardinal Health 提供 Monoject 和 Magellan 安全针头和注射器。

非安全针头成本低廉,并在正确使用的情况下提供无菌注射。细分市场的增长可归因于疫苗接种的常规使用以及发展中国家出生率的提高,需要更多的疫苗。 BD 制造的通用皮下注射针具有规则的斜面和壁,可提供额外平滑的静脉入口和最小的阻力。

皮下注射针市场,按类型 – 2021年和2028年

按应用划分

慢性病和疫苗接种需求维持该细分市场的主导地位

根据应用划分,全球皮下注射针头市场分为药物输送、疫苗接种和血液样本采集。药物输送领域在 2021 年占据市场主导地位,收入份额最大,预计在预测期内将创下最高复合年增长率。药物输送系统的注射模式为系统吸收提供了较大的表面积。这种细分市场的增长可以适应慢性病患病率的增加以及对疫苗、胰岛素、人类生长激素和现代药物的需求不断增加。此外,生物仿制药和低成本皮下注射针是给药的首选。几家公司正在对生物仿制药进行临床试验,这可能会在预测期内提供利润丰厚的机会。

疫苗接种领域是 2021 年的第二大市场占有者,具有相当大的需求和增长潜力。疫苗接种每年挽救数百万人的生命。世界各国政府正在大力投资,特别是在疫苗的帮助下,减轻全球疾病负担。疫苗接种通常被认为是预防任何可能导致医疗紧急情况的流行病的第一道防线。多个全球组织与地方政府合作,采取行动采购大量注射器和针头,用于疫苗接种。该细分市场的增长归因于日益增长的流行病潜力、对治疗性疫苗的重视以及新兴市场。

区域洞察

从地理上看,全球皮下注射针头市场分为北美、欧洲、 亚太地区 (APAC)、南美和南美地区中美洲 (SCAM)、中东和非洲非洲 (MEA)。

北美在 2021 年占据最大的市场份额,预计到 2028 年将保持主导地位。该地区最高的市场占有率归因于献血量的增加、传染病的流行、医院和临床实验室的高端基础设施、外科手术的增加以及主要市场参与者的发展。在美国,易患各种疾病的老年人口不断增加,癌症、糖尿病、慢性疼痛和胃肠道疾病病例不断增加,可能会引发皮下注射针头市场的增长。癌症、糖尿病和自身免疫性疾病在加拿大越来越普遍。大约 1100 万加拿大人患有糖尿病或糖尿病前期疾病。该国患有 1 型糖尿病的人需要频繁注射胰岛素,从而增加了对注射器和皮下注射针头的需求。

亚太地区皮下注射针头市场可能会在预测期内以最高的复合年增长率扩张。皮下注射针头的日益普及、医疗保健基础设施的发展、广泛的研发活动以及癌症、心血管疾病和糖尿病的高患病率是推动市场增长的主要参数。在中国,市场增长主要是由于血源性疾病、慢性病的患病率不断上升以及人们对可行治疗方案的认识。此外,该国的老年人群很可能患有多种慢性疾病。印度皮下注射针头市场的蓬勃发展得益于慢性病和生活方式相关疾病的增加、老年人口的不断增长以及人们对药物和医疗保健意识的不断增强。

皮下注射针头市场利润丰厚的地区

主要市场参与者:

  • Exelint International, Co.(美国)
  • Terumo Corporation(日本)
  • BD(美国)
  • B.Braun Melsungen AG(德国)
  • Catalent Inc(美国)
  • Cardinal Health Inc(美国)
  • Vita Needle Company (美国)
  • Connecticut Hypodermics Inc(美国)
  • Vygon(法国)
  • Nipro Corp(日本)
  • Barber of Sheffield (英国)
  • Retractable Technologies, Inc.(美国)
  • Air-Tite Products Co., Inc.(美国)

主要发展:< /h3>
  • 2018 年 12 月:Terumo 宣布在欧洲推出使用其 PLAJEX 预充式注射器的生物仿制药。
  • 2021 年 10 月:BD 在支持全球新冠疫情方面实现了 20 亿支注射装置的里程碑-19
    疫苗接种工作。
  • 2019 年 9 月:B.Braun 和飞利浦推出 Onvision 针尖跟踪,这是局部麻醉实时超声引导的突破。
< h3>报告覆盖范围

全球皮下注射针市场研究报告提供了对市场规模、份额、趋势和预测等方面的详细见解。它提供了关于驱动因素、限制因素、机会、细分市场和产业格局的清晰而精确的专业知识。讨论了 COVID-19 影响分析以及全球和区域市场的后果。一些主要市场参与者及其近年来各自的发展已被保留为特别提及。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is lucrative for the hypodermic needles market?

The Asia Pacific is offering lucrative opportunities for market growth owing to large patient population and increasing immunization across the region.

What are the driving factors for the hypodermic needles market across the globe?

The factors that are driving growth of the market are increasing chronic diseases prevalence, and surge in demand for vaccines.

Who are the developments carrying out by major players in the hypodermic needles market?

Various companies have made organic growth strategies in the hypodermic needles market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as BD, Cardinal Helath amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which type segment is expected to garner the highest traction within the hypodermic needles market??

The drug delivery segment is growing at the highest CAGR owing to increasing prevalence of chronic disease.

What are the strategies adopted by the top market players to penetrate across emerging regions?

New product launches, and acquisitions have helped the growth of market players across emerging regions.

The List of Companies - Hypodermic Needles Market

  1. EXELINT International, Co.
  2. Terumo Corporation
  3. BD
  4. B. Braun Melsungen AG
  5. Catalent Inc
  6. Cardinal Health Inc
  7. Vita Needle Company
  8. Connecticut Hypodermics Inc.
  9. Vygon
  10. Nipro
  11. Barber of Sheffield
  12. RETRACTABLE TECHNOLOGIES, INC.
  13. AIR-TITE PRODUCTS CO., INC.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports